Monthly Archives: October 2018

Brain Foundation research gift awarded

30 October 2018:

CNBP Associate Investigators Dr Lyndsey Collins-Praino (University of Adelaide) and Dr Andrew Care (Macquarie University), together with CNBP Director Prof Mark Hutchinson have been awarded a highly competitive Research Gift by the Australian Brain Foundation.

The funds granted will help the team to develop a new technique that aims to prevent the spread of Parkinson’s Disease in the human brain.

Below: Dr Lyndsey Collins-Praino and Dr Care accept their Research Award (with Prof Hutchinson in absentia).

 

 

Attending the Bridge Program Residential Training

2018/10/28 : : Dr Thomas Avery : Dr Thomas Avery attended the Bridge Program 3 day Residential Training course held at Macquarie University : RedXcross16x9 The Bridge Program is a consortium of 16 companies, universities and industry associations aiming to transfer practical skills on pharmaceutical commercialisation through training and direct exposure to industry practitioners.

Translating N‐Glycan Analytical Applications into Clinical Strategies for Ovarian Cancer

27 October 2018:

Translating N‐Glycan Analytical Applications into Clinical Strategies for Ovarian Cancer; Matthew T. Briggs, Mark R. Condina, Manuela Klingler‐Hoffmann, Georgia Arentz, Arun V. Everest‐Dass, Gurjeet Kaur, Martin K. Oehler, Nicolle H. Packer, Peter Hoffmann; Proteomics Clinical Apllications; DOI/10.1002/prca.201800099.

https://onlinelibrary.wiley.com/doi/abs/10.1002/prca.201800099

Best ECR presentation award

26 October 2018:

CNBP’s Dr Nisha Schwarz, has won ‘Best ECR Presentation’ at the South Australian Health and Medical Research Institute (SAHMRI) Research Showcase event, held Friday 26th October.

Nisha’s presentation was ‘Colchicine in CVD : An Ancient Therapeutic With Novel Applications. But How?’ During the talk she revealed some insights on its mechanisms specific to atherosclerosis.

Below – Nisha (middle) with other prize winners on the day.

Extremely rapid isotropic irradiation of nanoparticles with ions generated in situ by a nuclear reaction

26 Oct 2018

Extremely rapid isotropic irradiation of nanoparticles with ions generated in situ by a nuclear reaction;
Jan Havlik, Vladimira Petrakova, Jan Kucka, Helena Raabova, Dalibor Panek, Vaclav Stepan, Zuzana Zlamalova Cilova, Philipp Reineck, Jan Stursa, Jan Kucera, Martin Hruby & Petr Cigler;
Nature Communications; DOI: 10.1038/s41467-018-06789-8.

https://www.nature.com/articles/s41467-018-06789-8

'Ingenuity' promotes STEM study

23 October 2018:

‘Ingenuity’, a public facing event run by the Faculty of Engineering, Computer and Mathematical Sciences (University of Adelaide) was recently held at the Adelaide Convention Centre and CNBP science was represented!

The University event, showcasing final year student projects and achievements, was attended by thousands of school students, industry representatives and members of the general public, with the goal of encouraging and fostering an ongoing interest in STEM related subject areas (science, technology, engineering and maths).

This year saw CNBP PhD student Kathryn Palasis participate at the event, giving two presentations to approximately 300 school students on her research (the design and development of photoswitchable drugs) and describing her time at the University, with the aim of encouraging students to pursue a career in STEM.

“It was fantastic seeing the energy and interest in the room,” said Miss Palasis. “The feedback from staff and students was extremely positive and it was great to share my research and scientific passion with them all.”

“Hopefully we’ll see some of these young scientists studying at the University and then showcasing their own exciting areas of research in the years to come,” she said.

Below –  CNBP PhD student Kathryn Palasis delivers her talk.

 

QST partner launch

15 October 2018:

The ‘National Institutes for Quantum and Radiological Science and Technology (QST)’ has been announced as a partner organisation of the CNBP at an official launch event held in Japan, October 15th, 2018.

The QST, a merger of the National Institute of Radiological Sciences (NIRS) with operations that were previously undertaken by the Japan Atomic Energy Agency (JAEA), undertakes research and development into quantum science and technology, the effect of radiation on humans, radiation emergency medicine, and the medical use of radiation.

“The QST / CNBP partner launch was a huge success,” said CNBP Deputy Director A/Prof Brant Gibson, RMIT University.

“Our partner launch activities occurred over two site locations  of the QST – Takasaki and Chiba, Japan.”

“At the Takasaki ‘materials’ site I presented the CNBP partner plaque to Hisayoshi Itoh (pictured top left), Director General of the Takasaki site (Takasaki Advanced Radiation Research Institute).”

“Our delegation then moved to the Chiba ‘medical’ site of QST (National Institute of Radiological Sciences). There they have a medical high energy carbon irradiation facility – of which there are only two existent globally – the other is in Heidelberg in Germany. We had the opportunity to meet with Yoshiya Shimada, Executive Director of the entire QST at the Chiba site where I presented the CNBP plaque a second time,” he said.

The CNBP / QST partnership launch coincided with the launch of a 3 year International Research Initiative (entitled Quantum biosensors in wide bandgap semiconductors) between QST and researchers from RMIT, CNBP, The University of Melbourne, CQC2T and the Fraunhofer IAF.

“This initiative will focus on fostering strategic collaboration between Japan, Australia and Germany through short to long term visits from researchers focused in the area of quantum biology,” said A/Prof Gibson.

Below – A/Prof Brant Gibson with Yoshiya Shimada, Executive Director of the QST.

Below – QST and CNBP delegates pose for a partner launch photo at the QST Chiba site.

Glycan cancer research features on Nine News

13 October 2018:

Dr Arun Everest-Dass, CNBP researcher at the Institute for Glycomics at Griffith University has been interviewed by Nine News  about his glycan focused cancer research.

The interview took place during the Institution’s annual Glycomics Week activities, the aim of which is to draw attention to the significant glycan research taking place in the world of infectious disease, cancer and vaccine and drug discovery.

“It was a good opportunity to communicate our science to the wider community,” said Dr Everest-Dass.

“I explained to the news team our exciting new techniques and imaging technologies to help detect and analyse ovarian cancer. This is a key research area as ovarian cancer is the sixth most common cancer affecting Australian women.”

A clip of the interview can be found on the Nine News Twitter channel here.